Terms: = Breast cancer AND EGFR, mENA, 1956, ENSG00000146648, P00533, ERBB1, ERBB AND Staging
54 results:
1. Prognostic Values of CD8+, PARP, and egfr on Overall Survival in Patients with Triple-Negative breast cancer.
Putri RI; Haryono SJ; Brahma B; Prayitno YH; Sutandyo N
Asian Pac J Cancer Prev; 2024 Mar; 25(3):1025-1034. PubMed ID: 38546085
[TBL] [Abstract] [Full Text] [Related]
2. The Yin and Yang of erbb4: Tumor Suppressor and Oncoprotein.
Lucas LM; Dwivedi V; Senfeld JI; Cullum RL; Mill CP; Piazza JT; Bryant IN; Cook LJ; Miller ST; Lott JH; Kelley CM; Knerr EL; Markham JA; Kaufmann DP; Jacobi MA; Shen J; Riese DJ
Pharmacol Rev; 2022 Jan; 74(1):18-47. PubMed ID: 34987087
[TBL] [Abstract] [Full Text] [Related]
3. Gene expression analysis of invasive breast carcinoma yields differential patterns in luminal subtypes of breast cancer.
Abdelhafiz AS; Fouda MA; Elzefzafy NA; Taha II; Mohemmed OM; Alieldin NH; Toony I; Abdel Wahab AA; Farahat IG
Ann Diagn Pathol; 2021 Dec; 55():151814. PubMed ID: 34517157
[TBL] [Abstract] [Full Text] [Related]
4. Expressions of ZNF436, β-catenin, egfr, and CMTM5 in breast cancer and their clinical significances.
Chen Z; Cui N; Zhao JS; Wu JF; Ma F; Li C; Liu XY
Eur J Histochem; 2021 Jan; 65(1):. PubMed ID: 33478201
[TBL] [Abstract] [Full Text] [Related]
5. Clinicopathological and immunohistochemical characteristics of breast cancer patients from Northeast India with special reference to triple negative breast cancer: A prospective study.
Sultana R; Kataki AC; Barthakur BB; Sarma A; Bose S
Curr Probl Cancer; 2020 Oct; 44(5):100556. PubMed ID: 32044043
[TBL] [Abstract] [Full Text] [Related]
6. A novel epigenetic signature for overall survival prediction in patients with breast cancer.
Bao X; Anastasov N; Wang Y; Rosemann M
J Transl Med; 2019 Nov; 17(1):380. PubMed ID: 31747912
[TBL] [Abstract] [Full Text] [Related]
7. Targeted deep sequencing revealed variants in cell-free DNA of hormone receptor-positive metastatic breast cancer patients.
Keup C; Benyaa K; Hauch S; Sprenger-Haussels M; Tewes M; Mach P; Bittner AK; Kimmig R; Hahn P; Kasimir-Bauer S
Cell Mol Life Sci; 2020 Feb; 77(3):497-509. PubMed ID: 31254045
[TBL] [Abstract] [Full Text] [Related]
8. Relationship of Epidermal Growth Factor Receptor Expression with Clinical Symptoms and Metastasis of Invasive breast cancer.
Han L; Li L; Wang N; Xiong Y; Li Y; Gu Y
J Interferon Cytokine Res; 2018 Dec; 38(12):578-582. PubMed ID: 30431376
[TBL] [Abstract] [Full Text] [Related]
9. ZNF516 suppresses egfr by targeting the CtBP/LSD1/CoREST complex to chromatin.
Li L; Liu X; He L; Yang J; Pei F; Li W; Liu S; Chen Z; Xie G; Xu B; Ting X; Zhang Z; Jin T; Liu X; Zhang W; Yuan S; Yang Z; Wu C; Zhang Y; Yang X; Yi X; Liang J; Shang Y; Sun L
Nat Commun; 2017 Sep; 8(1):691. PubMed ID: 28947780
[TBL] [Abstract] [Full Text] [Related]
10. Gene Expression Signatures in Circulating Tumor Cells Correlate with Response to Therapy in Metastatic breast cancer.
Bredemeier M; Edimiris P; Mach P; Kubista M; Sjöback R; Rohlova E; Kolostova K; Hauch S; Aktas B; Tewes M; Kimmig R; Kasimir-Bauer S
Clin Chem; 2017 Oct; 63(10):1585-1593. PubMed ID: 28778937
[TBL] [Abstract] [Full Text] [Related]
11. The value of ultrasound-guided biopsy of fluorodeoxy-glucose positron emission tomography (FDG-PET)-positive supraclavicular lymph nodes in patients with suspected lung cancer.
Werner L; Keller FA; Bhure U; Roos JE; Tornquist K; Del Sol Pèrez-Lago M; Gautschi O; Strobel K
BMC Med Imaging; 2017 Jul; 17(1):41. PubMed ID: 28693444
[TBL] [Abstract] [Full Text] [Related]
12. Establishment of a multimarker qPCR panel for the molecular characterization of circulating tumor cells in blood samples of metastatic breast cancer patients during the course of palliative treatment.
Bredemeier M; Edimiris P; Tewes M; Mach P; Aktas B; Schellbach D; Wagner J; Kimmig R; Kasimir-Bauer S
Oncotarget; 2016 Jul; 7(27):41677-41690. PubMed ID: 27223437
[TBL] [Abstract] [Full Text] [Related]
13. Epidermal growth factor receptor gene polymorphisms are associated with prognostic features of breast cancer.
Leite MS; Giacomin LC; Piranda DN; Festa-Vasconcellos JS; Indio-do-Brasil V; Koifman S; de Moura-Neto RS; de Carvalho MA; Vianna-Jorge R
BMC Cancer; 2014 Mar; 14():190. PubMed ID: 24629097
[TBL] [Abstract] [Full Text] [Related]
14. [Expression of EZH2 in breast cancer and its clinicopathological significance].
Liu J; Wang H; Deng Y; Cao P; Li X
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2013 Jul; 42(4):443-9. PubMed ID: 24022934
[TBL] [Abstract] [Full Text] [Related]
15. Elevated transcription of the gene QSOX1 encoding quiescin Q6 sulfhydryl oxidase 1 in breast cancer.
Soloviev M; Esteves MP; Amiri F; Crompton MR; Rider CC
PLoS One; 2013; 8(2):e57327. PubMed ID: 23460839
[TBL] [Abstract] [Full Text] [Related]
16. 18F-FDG semi-quantitative parameters and biological prognostic factors in locally advanced breast cancer.
García Vicente AM; Soriano Castrejón A; Relea Calatayud F; Muñoz Madero V; Molina Garrido MJ; León Martín AA; Cordero García JM; Pilkington Woll JP; Chacón López-Muñiz I; Palomar Muñoz A
Rev Esp Med Nucl Imagen Mol; 2012; 31(6):308-14. PubMed ID: 23084013
[TBL] [Abstract] [Full Text] [Related]
17. 18F-FDG retention index and biologic prognostic parameters in breast cancer.
García Vicente AM; Castrejón ÁS; Relea Calatayud F; Muñoz AP; León Martín AA; López-Muñiz IC; Del Mar Muñoz Sánchez M; Cordero García JM; Becerra Nakayo EM
Clin Nucl Med; 2012 May; 37(5):460-6. PubMed ID: 22475895
[TBL] [Abstract] [Full Text] [Related]
18. Increased FDG uptake in breast cancer is associated with prognostic factors.
Sanli Y; Kuyumcu S; Ozkan ZG; Işik G; Karanlik H; Guzelbey B; Turkmen C; Ozel S; Yavuz E; Mudun A
Ann Nucl Med; 2012 May; 26(4):345-50. PubMed ID: 22359222
[TBL] [Abstract] [Full Text] [Related]
19. Correlated immunohistochemical and cytological assays for the prediction of hematogenous dissemination of breast cancer.
Oktay MH; Gertler FB; Liu YF; Rohan TE; Condeelis JS; Jones JG
J Histochem Cytochem; 2012 Mar; 60(3):168-73. PubMed ID: 22215635
[TBL] [Abstract] [Full Text] [Related]
20. Expression of Hypoxia-inducible factor 1-α and vascular endothelial growth factor-C in locally advanced breast cancer patients.
Brito LG; Schiavon VF; Andrade JM; Tiezzi DG; Peria FM; Marana HR
Clinics (Sao Paulo); 2011; 66(8):1313-20. PubMed ID: 21915477
[TBL] [Abstract] [Full Text] [Related]
[Next]
